These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


71 related items for PubMed ID: 5379889

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Therapy of gastro-duodenal ulcer, gastritis and gastroduodenitis with an antisecretory, non-anticholinergic drug (Milid)].
    Borellini D, Milvio C.
    Minerva Med; 1969 Mar 21; 60(23):1053-6. PubMed ID: 5781332
    [No Abstract] [Full Text] [Related]

  • 5. [Xylamide (Milid) therapy of gastroduodenitis in patients with saturnism].
    Gambini G, Grisler R.
    Minerva Med; 1969 Mar 21; 60(23):1017-23. PubMed ID: 5781327
    [No Abstract] [Full Text] [Related]

  • 6. [Inhibiting effects of Xylamide on induced maximal gastric acid secretion in humans].
    Sampietro R.
    Minerva Med; 1969 Mar 21; 60(23):1032-7. PubMed ID: 5781329
    [No Abstract] [Full Text] [Related]

  • 7. [Therapeutic activity in gastric and duodenal ulcers, gastritis and gastroduodenitis of an anti-secretory, non-anticholinergic drug].
    Bianchi PG, Saccabusi E.
    Minerva Med; 1969 Mar 21; 60(23):1044-52. PubMed ID: 5781331
    [No Abstract] [Full Text] [Related]

  • 8. [Evaluation of the antigastrin effect of xilamide].
    Laudano OM.
    Prensa Med Argent; 1968 Nov 29; 55(40):1896-8. PubMed ID: 5714058
    [No Abstract] [Full Text] [Related]

  • 9. [Pharmacological and clinical studies of a non-anticholinergic antisecretory product: Milid (xylamide, CR 242)].
    Mainoli S, Milvio C, Borellini D.
    Minerva Med; 1967 Oct 27; 58(86):3708-12. PubMed ID: 6061066
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Therapeutic value of the combination of a corticosteroid (prednisone) with a gastroprotective substance (xylamide)].
    Abbona C, Marugo M, Berretti A.
    Minerva Med; 1972 Sep 01; 63(60):3258-65. PubMed ID: 4559865
    [No Abstract] [Full Text] [Related]

  • 12. Effect of secretin and cholecystokinin on gastric emptying and gastric secretion in man.
    Chey WY, Hitanant S, Hendricks J, Lorber SH.
    Gastroenterology; 1970 Jun 01; 58(6):820-7. PubMed ID: 5423893
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacological studies on an antigastrin and antiulcer agent, SC-15396.
    Bianchi RG, Cook DL.
    Fed Proc; 1968 Jun 01; 27(6):1331-6. PubMed ID: 5725225
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Preliminary studies of the effects of xylamide on gastric secretion induced with caerulein].
    Mantovani P, Piccinin GL, Romano A.
    Boll Soc Ital Biol Sper; 1970 Mar 31; 46(6):279-81. PubMed ID: 5458653
    [No Abstract] [Full Text] [Related]

  • 18. Gastric secretion in patients with chronic pancreatitis and in chronic alcoholics.
    Chey WY, Kusakcioglu O, Dinoso V, Lorber SH.
    Arch Intern Med; 1968 Nov 31; 122(5):399-403. PubMed ID: 5687926
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Action of xylamide, CR 242, on gastric secretion of dogs after hypersecretory stimuli].
    Danhof IA.
    Minerva Med; 1967 Oct 27; 58(86):3670-7. PubMed ID: 6061060
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.